Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
castration resistant prostate cancer - Google News
Get the latest updates from castration resistant prostate cancer - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 2 years ago
Radiotherapy Treatments Are Getting Shorter and Faster in Prostate Cancer - OncLive
about 2 years ago
Radiotherapy Treatments Are Getting Shorter and Faster in Prostate Cancer OncLive
Lantern Pharma Inc. (NASDAQ:LTRN) to Post Q1 2022 Earnings of ($0.44) Per Share, Colliers Securities Forecasts - MarketBeat
about 2 years ago
Lantern Pharma Inc. (NASDAQ:LTRN) to Post Q1 2022 Earnings of ($0.44) Per...
The Risk of Prostate Cancer in Men with Inherited Germline TP53 Variants - Kara Maxwell - UroToday
about 2 years ago
The Risk of Prostate Cancer in Men with Inherited Germline TP53 Variants...
LYNPARZA® (olaparib) Reduced Risk of Death by 32% in Patients With Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer in Phase 3 OlympiA Trial - Joplin Globe
about 2 years ago
LYNPARZA® (olaparib) Reduced Risk of Death by 32% in Patients With Germline...
LYNPARZA® (olaparib) reduced risk of death by 32% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer - Bluefield Daily Telegraph
about 2 years ago
LYNPARZA® (olaparib) reduced risk of death by 32% in the adjuvant treatment...
LYNPARZA® (olaparib) reduced risk of death by 32% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer - StreetInsider.com
about 2 years ago
LYNPARZA® (olaparib) reduced risk of death by 32% in the adjuvant treatment...
Belgium's Precirix Beats Biotech Blues With Major Cash Boost - Scrip
about 2 years ago
Belgium's Precirix Beats Biotech Blues With Major Cash Boost Scrip
Merck Stops Trial of Pembrolizumab Plus Olaparib in Metastatic Castration-Resistant Prostate Cancer - Pharmacy Times
about 2 years ago
Merck Stops Trial of Pembrolizumab Plus Olaparib in Metastatic Castration-Resistant Prostate Cancer...
Precision Medicine Takes Hold of Prostate Cancer Management - OncLive
about 2 years ago
Precision Medicine Takes Hold of Prostate Cancer Management OncLive
Biotech execs who pinched Genentech trade secrets headed to prison - FiercePharma
about 2 years ago
Biotech execs who pinched Genentech trade secrets headed to prison FiercePharma
Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month data - FiercePharma
about 2 years ago
Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month...
MHRA request about ultrasound activation system holds up Exact Therapeutics' solid tumor trial - FiercePharma
about 2 years ago
MHRA request about ultrasound activation system holds up Exact Therapeutics' solid tumor...